Cargando…

BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates

The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Zak, P., Vejrazkova, E., Zavrelova, A., Pliskova, L., Ryskova, L., Hubacek, P., Stepanova, V., Kostal, M., Koblizek, V., Paterova, P., Radocha, Jakub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090732/
https://www.ncbi.nlm.nih.gov/pubmed/31073843
http://dx.doi.org/10.1007/s12223-019-00712-4
_version_ 1783509951841304576
author Zak, P.
Vejrazkova, E.
Zavrelova, A.
Pliskova, L.
Ryskova, L.
Hubacek, P.
Stepanova, V.
Kostal, M.
Koblizek, V.
Paterova, P.
Radocha, Jakub
author_facet Zak, P.
Vejrazkova, E.
Zavrelova, A.
Pliskova, L.
Ryskova, L.
Hubacek, P.
Stepanova, V.
Kostal, M.
Koblizek, V.
Paterova, P.
Radocha, Jakub
author_sort Zak, P.
collection PubMed
description The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12223-019-00712-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7090732
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-70907322020-03-24 BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates Zak, P. Vejrazkova, E. Zavrelova, A. Pliskova, L. Ryskova, L. Hubacek, P. Stepanova, V. Kostal, M. Koblizek, V. Paterova, P. Radocha, Jakub Folia Microbiol (Praha) Original Article The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12223-019-00712-4) contains supplementary material, which is available to authorized users. Springer Netherlands 2019-05-09 2020 /pmc/articles/PMC7090732/ /pubmed/31073843 http://dx.doi.org/10.1007/s12223-019-00712-4 Text en © Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i. 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Zak, P.
Vejrazkova, E.
Zavrelova, A.
Pliskova, L.
Ryskova, L.
Hubacek, P.
Stepanova, V.
Kostal, M.
Koblizek, V.
Paterova, P.
Radocha, Jakub
BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
title BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
title_full BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
title_fullStr BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
title_full_unstemmed BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
title_short BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
title_sort bal fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090732/
https://www.ncbi.nlm.nih.gov/pubmed/31073843
http://dx.doi.org/10.1007/s12223-019-00712-4
work_keys_str_mv AT zakp balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT vejrazkovae balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT zavrelovaa balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT pliskoval balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT ryskoval balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT hubacekp balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT stepanovav balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT kostalm balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT koblizekv balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT paterovap balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates
AT radochajakub balfluidanalysisintheidentificationofinfectiousagentsinpatientswithhematologicalmalignanciesandpulmonaryinfiltrates